NCT04131595View on ClinicalTrials.gov

Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

July 22, 2020

Study Completion Date

July 22, 2020

Conditions

Equine Encephalitis

Interventions

BIOLOGICAL

MVA-BN-WEV Dose 1

1 x 10\^7 Inf.U MVA-BN-WEV vaccine

BIOLOGICAL

MVA-BN-WEV Dose 2

1 x 10\^8 Inf.U MVA-BN-WEV vaccine

BIOLOGICAL

MVA-BN-WEV Dose 3

2 x 10\^8 Inf.U MVA-BN-WEV vaccine.

Trial Locations (1)

66219

Johnson County Clin-Trials, Lenexa

Sponsors

Lead Sponsor

Bavarian Nordic

Collaborators (1)

JPM CBRN Medical

All Listed Sponsors

collaborator

JPM CBRN Medical

UNKNOWN

lead

Bavarian Nordic

INDUSTRY

NCT04131595 - Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter